South Asia and Beyond

Expert Panel Clears Covaxin For 2-18 Age Group

India’s homegrown Coronavirus vaccine Covaxin, developed by Bharat Biotech, has been approved for emergency use for the 2-18 age group. The expert committee on vaccination made the recommendation. The vaccine is already used for adults, delivering, according to various reports, 71 per cent efficacy against the Coronavirus and its variants.

Related